Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.PSYC Names Daniel Jaros as Interim CEO, Retires $300K+ Debt
PSYC Begins Business Overhaul Process with Consolidation of 10 Previously Issued Convertible Debentures
PSYC's CEO Provides Detailed Update on the State of the Company in Newly Released Podcast Recording
PSYC's CEO to Moderate Panel at The Cannabis & Psychedelics Investment Summit Hosted by Kahner Global
PSYC's Psychedelic Spotlight to be Media Partner for 2023 reMind Psychedelic Business Forum
PSYC Acquires Stock Day Media to Help Bolster Revenue Production Capacity
PSYC Enters Strategic Partnership with Target Media to Help Accelerate Audience and Revenue Growth Opportunities
Cybin, MindMed, and Field Trip Health Headline PSYC's First CEO Round Table Event
PSYC's Psychedelic Spotlight Nets Over 230K Page Views in August
Global Trac Solutions, Inc. Discusses Launch of Paid Partnership Media Services and Future Monetization Strategies with The Stock Day Podcast
PSYC Launches Paid Media Partnership Services for Growing Medicinal Psychedelics Industry
PSYC Looks to Acquire Additional Equity in Digital Mental Health Startup, PsycheDev Inc.
PSYC Interviews CA Senator Scott Wiener to Discuss Efforts to Legalize Psychedelics
PSYC Engages Auditing Firm for Audit of 2020 Financials
PSYC CEO Discusses Increasing Audience, Recent Investments in The Medicinal Psychedelic Space, and Upcoming Financial Audit with The Stock Day Podcast
Global Trac Solutions Reports Record Pageviews Of Psychedelics Industry Indicate An Expanding Interest In The Sector
PSYC Continues to Amass Sizable Audience Within Emerging Medicinal Psychedelics Industry
PSYC's Psychedelic Spotlight Achieves Milestone With 100K+ Page Views in April
PSYC CEO, David Flores, To Be Featured on Live Cheddar TV Segment
PSYC Provides Update on Progress with PsycheDev Inc.